ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GSK Gsk Plc

1,708.60
3.40 (0.20%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  3.40 0.20% 1,708.60 1,708.60 1,708.80 1,713.00 1,699.40 1,701.60 11,522,668 16:29:59
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.27 70.34B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,705.20p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,719.80p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £70.34 billion. Gsk has a price to earnings ratio (PE ratio) of 14.27.

Gsk Share Discussion Threads

Showing 27726 to 27747 of 33075 messages
Chat Pages: Latest  1119  1118  1117  1116  1115  1114  1113  1112  1111  1110  1109  1108  Older
DateSubjectAuthorDiscuss
26/7/2021
13:58
GSK like a hot potato.
netcurtains
26/7/2021
13:34
Rising Delta variant in the US possibly impacting their wider vaccine business
may be one of the reasons for share price weakness, just imv obvs.

essentialinvestor
26/7/2021
12:12
EW resignation RNS = Circa £1 on the share price. spud
spud
26/7/2021
11:02
All - or then again, nothing much - will be revealed on Wed. The rest is speculation.......
keyno
26/7/2021
10:27
There is no feasible way the status quo can remain whilst the share price keeps falling
spoole5
26/7/2021
10:20
The heat has gotta be rising. Another crucial week for Emma
spoole5
26/7/2021
10:14
GlaxoSmithKline's Demerger Plan Has Failed To Excite Investors
Summary

GSK’s plan to spin off its consumer healthcare division has not led to a substantial revaluation of the group.

It is planning to spin off at least 80% of its stake in the consumer business by mid-
2022, with a view to selling the remaining interest at a later date.

Dividends will be cut by 31% in 2022, as the company seeks to repair its balance sheet and prioritize R&D spending.

geckotheglorious
26/7/2021
09:54
A sale of 100% of consumer is what Elliot wants and perhaps Elliot is right. Delay the sale and we risk missing the boat.
tombag
26/7/2021
09:50
Keyno, It came up on stockopedia, but it could just be Aimees view on Twitter, unsure, but does make sense as they can focus on Biochem etc rather than toothpaste, expect we will find out the truth on Weds
GLA

charlie9038
26/7/2021
09:44
I thought that a sale wasn't on the table as far as GSK are concerned. Sounds like some are expecting a different tack with results on Wed. I wouldn't hold your breath. I want value here too and we aren't getting any as things stand.
keyno
26/7/2021
09:41
Indeed Ftse seems to be in lock step with US futures, which ticked up a little. Wonder if our beloved will join in ?
andyadvfn1
26/7/2021
09:39
Keyno: I did say over the weekend that the important thing was the cost of toothpaste etc but some poohpoohed the idea. But in reality the selling of the consumer side is what is going to shift this price.
netcurtains
26/7/2021
09:36
Isn't this [#747] just the view of Aimee Donnellan - whoever she is?
keyno
26/7/2021
09:34
Its falling, like all of FTSE, as American futures have done a belly flop
netcurtains
26/7/2021
09:32
Doesn't stop it falling though!!
spoole5
26/7/2021
09:32
That's almost 80% of current market cap
spoole5
26/7/2021
09:04
That would be interesting.
alex1621
26/7/2021
07:46
Spoole5: With the incredibly low share price I think we can say bad figures are already factored into the price.
If the figures were expected to be good it would not be 1400 it would be 2000.
I guess we're talking about how relatively bad.
If only slightly relatively bad could rise to 1500
If expected bad could settle about 1425
if worse than bad could go to 1300

netcurtains
26/7/2021
07:35
She can't afford to disappoint this week
spoole5
25/7/2021
08:14
Mail on Sunday short article suggesting GSK will post improving revenues next week.
alex1621
24/7/2021
15:38
spud: you said "consumer division will probably be taken out"....

That is my very point!
The more profit it makes NOW the better price we will get for it.

To my mind the URGENT profit is the consumer profit because its basically up for sale.

The pharma side really needs good trial results and good promises of future growth.

The consumer side needs good growth story NOW as its up for sale NOW.

netcurtains
24/7/2021
15:30
It a Sun exclusive story..........covid built on fraud



Bernie's Tweets
@BernieSpofforth
If this is actually happening then it needs a full investigation by the Police & the head of Gov procurement needs to lose their job.

We’ve sacrificed far to much because incompetence, criminal activity and greed is allowed to continue.

jimarilo
Chat Pages: Latest  1119  1118  1117  1116  1115  1114  1113  1112  1111  1110  1109  1108  Older

Your Recent History

Delayed Upgrade Clock